FSD Pharma Inc. (HUGE )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol HUGE
- Company FSD Pharma Inc.
- Price $0.09
- Changes Percentage -10.1
- Change -0.0101
- Day Low $0.09
- Day High $0.1
- Year High $109.19
- Year Low $0.09
- Market Cap $66,671
- Price Avg 50 EMA (D) $8.13
- Price Avg 200 EMA (D) $36.69
- Exchange NASDAQ
- Volume 22,015,006
- Average Volume 196,163
- Open $0.1
- Previous Close $0.1
- EPS -16.25
- PE -0.01
- Earnings Announcement 2024-11-12 00:00:00
- Shares Outstanding $741,612
Company brief: FSD PHARMA INC. (HUGE )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Zeeshan Saeed
- https://www.fsdpharma.com
- CA
- N/A
- 06-08-2018
- CA35954B4047
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.